Pharmaceutical Logistics Market Size

ID: MRFR/PCM/10020-HCR

200 Pages

Varsha More

February 2026

Pharmaceutical Logistics Market Research Report By Service Type (Transportation, Warehousing, Distribution, Packaging), By Temperature Control (Ambient, Cold Chain, Controlled Room Temperature), By End User (Pharmaceutical Manufacturers, Healthcare Providers, Retail Pharmacies, Third-Party Logistics Providers), By Mode of Transport (Air Freight, Sea Freight, Land Transport) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Pharmaceutical Logistics Size

Pharmaceutical Logistics Market Growth Projections and Opportunities

Many factors shape the pharmaceutical logistics market. Consistency in administration is crucial. Pharmaceutical products must meet strict rules to ensure their safety and viability, therefore logistics providers must consider sophisticated consistency requirements.

The pharmaceutical logistics market was worth USD 84.2 Billion in 2022 and is expected to grow from USD 92.2 Billion in 2023 to USD 190.6 Billion in 2032, a CAGR of 9.50%.

Innovative scene is another market aspect. Innovations like temperature-sensitive monitoring systems and track-and-follow systems are vital in pharmaceutical logistics. The need for constant perceivability and information-driven navigation has led to the integration of innovation into logistics, improving efficiency and reducing the risk of item deterioration or misfortune during transportation

Globalization shapes the pharmaceutical logistics market. Pharmaceutical companies are expanding beyond domestic lines, increasing demand for cross-line logistics. This globalization trend demands robust retail network networks to connect manufacturers, merchants, and medical services suppliers across locations to ensure safe and convenient pharmaceutical product delivery.

The ongoing logistical reappropriation also impacts the market. The logistics capabilities of pharmaceutical companies are increasingly outsourced. Reappropriating lets these companies focus on their strengths while using logistics professionals. Pharmaceutical products are fragile, hence specific capacity conditions are essential. Temperature-controlled transit and storage increase pharmaceutical logistics costs. Logistics suppliers in this industry struggle to adjust demanding capacity requirements cost-effectively.

Market competition and consolidation are important. As pharmaceutical logistics grows, logistics suppliers compete. Organizations differentiate themselves through service excellence and administrative efficiency. Consolidations and acquisitions have also occurred, with larger logistics companies acquiring pharmaceutical firms to increase their capacities.

Innovative delivery models are revolutionizing pharmaceutical logistics. Direct-to-patient (DTP) and last-mile delivery services are redefining distribution models. These developments aim to maintain success by ensuring timely drug access and reducing reliance on traditional delivery systems.

Pharmaceutical companies and their logistical partners are studying eco friendly solutions as corporate social responsibility grows. Electric cars and maintainable bundling are promoting greener logistical practices in the industry.

Market Highlights

Author

Varsha More

Research Analyst

Experienced business professional with a demonstrated history of working in the CFnB industry. Skilled in market research, and market estimation. Strong professional with a Masters focused in marketing management.

Get In Touch

FAQs

What is the expected market size of the Pharmaceutical Logistics Market in 2024?

The Pharmaceutical Logistics Market is expected to be valued at 95.88 USD billion in 2024.

What is the expected CAGR for the Pharmaceutical Logistics Market from 2025 to 2035?

Pharmaceutical Logistics Market is projected to grow at a CAGR of 9.5% during the forecast period, 2025-2035

Which region is expected to dominate the Pharmaceutical Logistics Market in 2024?

North America is expected to dominate the market with a valuation of 38.0 USD Billion in 2024.

How much is the Pharmaceutical Logistics Market expected to grow in Europe by 2035?

The market in Europe is anticipated to grow to 45.0 USD billion by 2035.

What are the leading players in the Pharmaceutical Logistics Market?

Some of the key players in the market include FedEx, XPO Logistics, DHL, and Kuehne + Nagel.

Which segment of the Pharmaceutical Logistics Market is projected to see the highest growth rate until 2035?

Transportation is projected to be the leading segment during the forecast period, with significant growth.

What is the expected value of the Warehousing segment in 2024?

The Warehousing segment is expected to be valued at 25.0 USD Billion in 2024.

What will be the market size for the Asia Pacific region in 2035?

The Asia Pacific region is expected to reach a market size of 25.0 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Global Pharmaceutical Logistics Market was valued at USD 100.96 Billion in 2024 and is projected to grow to USD 274.03 Billion by 2035, with a CAGR of approximately 4.16% from 2025 to 2035. The market is driven by the increasing demand for temperature-sensitive pharmaceuticals, advancements in technology, and the rapid expansion of biopharmaceuticals. Companies are investing in specialized logistics solutions to ensure compliance with stringent regulations and to enhance operational efficiency.

Key Market Trends & Highlights

The Global Pharmaceutical Logistics Market is experiencing significant transformation driven by key trends.

Transportation segment valued at USD 30.0 Billion in 2024, projected to reach USD 274.03 Billion by 2035.
Cold Chain logistics is crucial for the distribution of temperature-sensitive products, with 25% to 30% of pharmaceuticals requiring strict temperature controls.
North America leads the market with a valuation of USD 42.5 Billion in 2024, expected to grow to USD 65.0 Billion by 2035.
Approximately 75% of pharmaceutical companies are investing in advanced tracking systems to enhance logistics efficiency.

Market Size & Forecast

2024 Market Size	USD 100.96 Billion
2035 Market Size	USD 274.03 Billion
CAGR (2025-2035)	9.50%
Largest Regional Market Share in 2024	North America.

Major Players

Key players include DB Schenker, TNT Express, FedEx, DHL Supply Chain, and Kuehne + Nagel.

Market Trends

Significant trends are currently being observed in the Pharmaceutical Logistics Market, which is being driven by the demand for healthcare services and the necessity for efficient supply chain solutions. The increasing complexity of pharmaceutical products, particularly biologics and specialty medications, necessitates sophisticated logistics solutions for regulatory compliance and temperature-sensitive transport, which is a significant market driver.

The growth of the healthcare sector is also influenced by the expansion of e-commerce, as an increasing number of pharmaceutical companies are seeking dependable logistics partners for direct-to-consumer deliveries. In the logistics sector, there has been a recent trend toward digitization, as numerous companies have implemented automated systems and technologies, including blockchain and IoT, to improve the visibility and efficacy of their supply chains. This trend not only enhances inventory management but also mitigates the risk of errors, thereby guaranteeing that medications are delivered to patients in the appropriate condition and on time.

Moreover, pharmaceutical logistics is increasingly emphasizing sustainability, as organizations strive to mitigate their environmental footprint by implementing optimized transportation methods and eco-friendly packaging.

Additionally, there are opportunities in emerging markets, where the demand for healthcare is increasing. Logistics companies may consider establishing partnerships to improve their service offerings in these regions as governments worldwide continue to invest in healthcare infrastructure.

Additionally, the pharmaceutical industry is focused on adhering to rigorous temperature control standards in order to preserve the efficacy of its products. Consequently, the significance of cold chain logistics is on the rise. In general, the Pharmaceutical Logistics Market is on the brink of a transformation, which is being fueled by the development of technological advancements and the changing requirements of customers.

Pharmaceutical Logistics Market Market Drivers

E-commerce Growth

The growth of e-commerce is reshaping the pharmaceutical logistics market. With an increasing number of consumers opting for online purchases of medications and health products, logistics providers are compelled to adapt their strategies to meet this demand. The e-pharmacy sector is projected to grow at a CAGR of 15% over the next five years, indicating a substantial shift in consumer behavior. This trend necessitates the development of efficient last-mile delivery solutions and enhanced inventory management systems. As a result, logistics companies are investing in technology and infrastructure to streamline operations and ensure timely delivery of pharmaceutical products, thereby driving growth in the pharmaceutical logistics market.

Regulatory Compliance

Regulatory compliance remains a critical driver in the pharmaceutical logistics market. Stringent regulations imposed by health authorities necessitate that logistics providers adhere to specific standards for the storage and transportation of pharmaceutical products. Compliance with Good Distribution Practices (GDP) and other regulatory frameworks is essential to ensure product integrity and patient safety. The increasing complexity of regulations across different regions adds to the operational challenges faced by logistics providers. As a result, companies that invest in compliance management systems are likely to gain a competitive edge. The market for compliance solutions is expected to grow significantly, reflecting the ongoing need for adherence to regulatory standards in the pharmaceutical logistics market.

Focus on Sustainability

Sustainability is becoming an increasingly important driver in the pharmaceutical logistics market. As environmental concerns gain prominence, logistics providers are under pressure to adopt sustainable practices. This includes optimizing transportation routes to reduce carbon emissions and implementing eco-friendly packaging solutions. Companies that prioritize sustainability are likely to enhance their brand reputation and appeal to environmentally conscious consumers. According to recent studies, logistics companies that adopt sustainable practices can reduce operational costs by up to 20%. This focus on sustainability not only addresses regulatory pressures but also aligns with the growing demand for corporate social responsibility in the pharmaceutical logistics market.

Technological Advancements

The pharmaceutical logistics market is experiencing a notable transformation due to rapid technological advancements. Innovations such as automation, artificial intelligence, and blockchain are enhancing operational efficiency and transparency. For instance, the integration of AI in supply chain management allows for predictive analytics, which can optimize inventory levels and reduce waste. Furthermore, blockchain technology is being utilized to ensure traceability and security in the supply chain, addressing concerns related to counterfeit drugs. According to recent data, the adoption of these technologies is projected to increase operational efficiency by up to 30% in the pharmaceutical logistics market, thereby driving growth and improving service delivery.

Rising Demand for Biopharmaceuticals

The rising demand for biopharmaceuticals is significantly influencing the pharmaceutical logistics market. Biopharmaceuticals, which include biologics and biosimilars, require specialized handling and transportation due to their sensitivity to temperature and environmental conditions. The market for biopharmaceuticals is projected to reach USD 500 billion by 2026, necessitating robust logistics solutions that can accommodate these products. This surge in demand is prompting logistics providers to enhance their cold chain capabilities and invest in advanced tracking technologies. Consequently, the pharmaceutical logistics market is adapting to meet the unique requirements of biopharmaceuticals, thereby driving innovation and growth.

Market Segment Insights

By Application: Cold Chain Logistics (Largest) vs. Transportation (Fastest-Growing)

Within the pharmaceutical logistics market, the application segment reveals a dynamic competition among various values. Cold Chain Logistics commands the largest share due to the stringent requirements for temperature-sensitive products, such as vaccines and biologics. This segment ensures that products are maintained at required temperatures throughout the transportation and storage phases, thus safeguarding their efficacy. In contrast, Transportation has been identified as the fastest-growing segment, driven by an increasing demand for efficient delivery systems and greater reliance on real-time tracking technologies.

Cold Chain Logistics (Dominant) vs. Inventory Management (Emerging)

Cold Chain Logistics stands as the dominant force in pharmaceutical logistics, primarily catering to the special requirements of temperature-controlled products. It encompasses specialized transportation and storage solutions that guarantee product integrity from manufacturer to patient. The sector leverages advanced refrigeration technologies and compliance with regulatory standards. On the other hand, Inventory Management is emerging as a key player in optimizing drug distribution. Its role is crucial for ensuring that pharmaceutical companies maintain adequate supply levels while minimizing wastage. As the industry continues to evolve, the emphasis on efficient inventory practices will become critical, making it an essential component of the logistics framework.

By End Use: Healthcare Institutions (Largest) vs. Contract Logistics Providers (Fastest-Growing)

The pharmaceutical logistics market is composed of several key end-use segments, each playing a crucial role in ensuring the efficient distribution of pharmaceutical products. Among these, Healthcare Institutions represent the largest share, as they require a consistent and reliable supply chain for the delivery of medications to patients. On the other hand, Contract Logistics Providers are rapidly gaining traction, driven by their ability to offer specialized services tailored to the pharmaceutical sector.

Healthcare Institutions (Dominant) vs. Contract Logistics Providers (Emerging)

Healthcare Institutions dominate the pharmaceutical logistics space, characterized by their extensive networks of hospitals, clinics, and care facilities that necessitate robust logistics solutions. These institutions often deal with high volumes of various pharmaceutical products, including vaccines, generics, and specialty drugs, requiring precise temperature-controlled transport and stringent compliance with regulatory standards. Conversely, Contract Logistics Providers are emerging as vital players, providing flexible and scalable logistics solutions designed to meet the evolving needs of pharmaceutical manufacturers. They have adapted quickly to changes in the market, employing advanced technologies and software to enhance supply chain visibility and efficiency.

By Service Type: Transportation Services (Largest) vs. Packaging Services (Fastest-Growing)

In the pharmaceutical logistics market, the service type segment is primarily dominated by Transportation Services, which account for the largest market share. This segment encompasses activities related to the shipping of pharmaceutical goods across various channels, including domestic and international shipping. Packaging Services, while not the largest, are rapidly gaining ground due to the increasing need for compliance with stringent regulations regarding the handling and transport of sensitive pharmaceutical products.

Transportation Services (Dominant) vs. Packaging Services (Emerging)

Transportation Services play a crucial role in the pharmaceutical logistics market as they ensure the efficient and safe delivery of drugs to various stakeholders, including healthcare providers and pharmacies. This service is characterized by well-established networks and protocols to maintain the integrity of pharmaceutical products during transit. In contrast, Packaging Services have emerged recently, driven by advancements in technology and the rising demand for innovative packaging solutions that not only protect pharmaceuticals but also enhance their shelf life. This includes temperature-controlled packaging and tamper-evident solutions, which are becoming increasingly important in the face of regulatory pressures.

By Temperature Control: Refrigerated Temperature (Largest) vs. Frozen Temperature (Fastest-Growing)

In the pharmaceutical logistics market, the temperature control segment is chiefly divided into three categories: ambient, refrigerated, and frozen temperature solutions. Refrigerated temperature logistics dominate this segment, accounting for the greatest market share due to the extensive requirements for temperature-sensitive pharmaceuticals such as vaccines and biologics. Ambient temperature solutions occupy a notable portion of the market as well, primarily catering to pharmaceuticals that do not necessitate stringent temperature controls.

Refrigerated Temperature (Dominant) vs. Frozen Temperature (Emerging)

Refrigerated temperature logistics play a pivotal role in the pharmaceutical sector, as they ensure the integrity of temperature-sensitive products throughout the supply chain. This segment is characterized by stringent compliance standards and advanced monitoring technologies that facilitate a secure logistics environment for pharmaceuticals demanding consistent refrigeration. Conversely, frozen temperature logistics, marked as an emerging segment, cater to an expanding range of products, such as gene therapies and advanced therapeutics. The rapid growth in this category is driven by increased investments in biotechnology and the rising prevalence of cold chain demand, reflecting a shift towards more innovative therapies that necessitate frozen storage solutions.

By Logistics Model: Third Party Logistics (Largest) vs. Fourth Party Logistics (Fastest-Growing)

In the pharmaceutical logistics market, Third Party Logistics (3PL) dominates the landscape, providing essential services like warehousing, distribution, and transportation. It accounts for a significant portion of the market share, reflecting its established presence and reliability for pharmaceutical companies seeking efficient supply chain solutions. In comparison, Fourth Party Logistics (4PL) is emerging with growing popularity, characterized by its integrated approach that combines advanced technology and logistics to manage a more complex supply chain effectively.

Third Party Logistics (Dominant) vs. Fourth Party Logistics (Emerging)

Third Party Logistics (3PL) plays a crucial role in the pharmaceutical sector by offering specialized services that cater to the unique needs of this industry, including temperature-controlled transportation and compliance with regulatory standards. It allows pharmaceutical companies to focus on their core activities while relying on 3PL providers for logistics efficiency. Meanwhile, Fourth Party Logistics (4PL) is revolutionizing the market by leveraging technology such as IoT and big data analytics, granting businesses greater visibility and control over their logistics operations. As the demand for end-to-end solutions in the pharmaceutical industry grows, 4PL is positioned as an emerging leader that facilitates agility and responsiveness in supply chain management.

Get more detailed insights about Pharmaceutical Logistics Market Research Report—Global Forecast till 2035

Regional Insights

The Pharmaceutical Logistics Market is poised for growth, with significant revenue distribution across various regions. In 2024, North America accounts for a majority holding with a valuation of 38.0 USD billion, expected to rise to 60.0 USD billion by 2035, showcasing its dominant position due to advanced healthcare infrastructure and stringent regulatory frameworks.

Europe follows, valued at 28.0 USD billion in 2024 and projected to reach 45.0 USD billion by 2035, benefiting from a robust pharmaceutical industry and increasing demand for temperature-sensitive logistics.South America, while smaller, shows potential with a valuation of 6.5 USD Billion in 2024, growing to 10.5 USD Billion, as governments focus on improving healthcare access. The Asia Pacific region is expected to reach 18.0 USD Billion in 2024 and is expected to expand to 25.0 USD billion, driven by a surge in pharmaceutical production and evolving logistics capabilities.

Lastly, the Middle East and Africa, valued at 5.38 USD billion in 2024 and anticipated to grow to 9.0 USD billion, illustrate emerging opportunities, particularly through investments in healthcare facilities and infrastructure.Each region contributes uniquely to the Pharmaceutical Logistics Market landscape, reflecting varying growth drivers and challenges that present opportunities for stakeholders.

Key Players and Competitive Insights

The Pharmaceutical Logistics Market has evolved significantly amidst escalating demand for efficiency and compliance in the transportation and storage of pharmaceutical goods. This market is characterized by a highly regulated environment, driven by stringent safety standards and the need for temperature-sensitive logistics solutions. Competitive insights reveal that companies are investing in advanced technologies and innovative solutions to optimize their supply chains.
Key players are focusing on enhancing their distribution capabilities, expanding their global presence, and ensuring the timely delivery of pharmaceuticals while adhering to the required regulatory frameworks. Collaboration with stakeholders, including manufacturers and healthcare providers, plays a crucial role in shaping the competitive landscape as these firms strive to respond effectively to the growing complexity and globalization of the pharmaceutical supply chain.FedEx has carved out a formidable presence in the Pharmaceutical Logistics Market, leveraging its extensive network and advanced logistics solutions to cater to the specific needs of pharmaceutical clients.
The company excels in providing time-sensitive delivery options, ensuring that products are delivered within the requisite timeframes, which is essential for pharmaceuticals. FedEx offers specialized services that comply with strict regulatory requirements, including temperature-controlled transportation.
Furthermore, the company integrates cutting-edge technology to provide real-time tracking and visibility, enhancing customer confidence. The strong brand reputation and reliability associated with FedEx are significant strengths that distinguish it from competitors, as pharmaceutical companies seek partners that not only understand their logistics requirements but can also ensure safety and efficiency in every delivery.XPO Logistics holds a strong position in the Pharmaceutical Logistics Market, recognized for its comprehensive range of services designed specifically for the life sciences industry. The company's offerings include warehousing, transportation, and distribution solutions tailored to meet the unique needs of pharmaceuticals, biologics, and medical devices.
XPO Logistics excels in utilizing technology-driven solutions, including digital freight platforms and data analytics, that optimize routes and enhance inventory management.
Additionally, strategic mergers and acquisitions have enabled XPO Logistics to expand its geographic footprint and enhance its service capabilities across global markets. The company’s commitment to regulatory compliance and quality assurance further reinforces its reputation as a trusted logistics partner in the pharmaceutical sector. Overall, XPO Logistics stands out for its innovative approach to logistics management, helping companies navigate the complexities of global pharmaceutical supply chains with efficiency and reliability.

Key Companies in the Pharmaceutical Logistics Market include

Industry Developments

Q2 2024: UPS to acquire Canadian healthcare logistics firm Andlauer Healthcare for $1.6 billion UPS announced the acquisition of Andlauer Healthcare Group, a leading Canadian pharmaceutical logistics provider, for $1.6 billion to expand its healthcare logistics capabilities in North America.
Q2 2024: CEVA Logistics completes integration of Bolloré Logistics’ healthcare division CEVA Logistics finalized the integration of Bolloré Logistics’ healthcare division, strengthening its position in pharmaceutical logistics and expanding its global cold chain network.
Q2 2024: FedEx opens new cold chain facility in Singapore to support pharmaceutical logistics in Asia Pacific FedEx inaugurated a state-of-the-art cold chain facility in Singapore, enhancing its ability to handle temperature-sensitive pharmaceutical shipments across the Asia Pacific region.
Q1 2024: DHL Supply Chain opens new pharmaceutical logistics center in Madrid DHL Supply Chain launched a new logistics center in Madrid dedicated to pharmaceutical products, featuring advanced temperature-controlled storage and distribution capabilities.
Q2 2024: UPS Healthcare expands European footprint with new facility in Italy UPS Healthcare opened a new logistics facility in Italy, designed to support the growing demand for pharmaceutical distribution and cold chain logistics in Southern Europe.
Q1 2024: Cardinal Health launches new pharmaceutical distribution center in Texas Cardinal Health opened a new distribution center in Texas to enhance its pharmaceutical logistics network and improve delivery times for healthcare providers in the region.
Q2 2024: Kuehne+Nagel acquires majority stake in Chinese pharma logistics firm Kuehne+Nagel acquired a majority stake in a leading Chinese pharmaceutical logistics company, expanding its presence in the fast-growing Asia-Pacific healthcare logistics market.
Q1 2024: FedEx appoints new head of global healthcare logistics division FedEx named a new executive to lead its global healthcare logistics division, aiming to accelerate growth in pharmaceutical and medical supply chain services.
Q2 2024: McKesson signs multi-year pharmaceutical logistics contract with major US hospital network McKesson secured a multi-year contract to provide pharmaceutical logistics and distribution services to one of the largest hospital networks in the United States.
Q1 2024: UPS Healthcare launches new temperature-controlled packaging solution for biologics UPS Healthcare introduced a new packaging solution designed to maintain strict temperature controls for the transportation of biologic drugs and vaccines.
Q2 2024: CEVA Logistics wins contract to manage vaccine distribution for European government CEVA Logistics was awarded a contract to manage the distribution of vaccines for a European government, leveraging its specialized pharmaceutical logistics infrastructure.
Q1 2024: DHL partners with biotech firm to provide end-to-end clinical trial logistics DHL announced a partnership with a leading biotech company to deliver comprehensive logistics solutions for clinical trial materials, including temperature-sensitive pharmaceuticals.

Future Outlook

Pharmaceutical Logistics Market Future Outlook

The pharmaceutical logistics market is projected to grow at a 4.75% CAGR from 2024 to 2035, driven by technological advancements, regulatory changes, and increasing demand for temperature-sensitive products.

New opportunities lie in:

Implementation of automated inventory management systems
Expansion of cold chain logistics capabilities
Development of blockchain-based supply chain transparency solutions

By 2035, the pharmaceutical logistics market is expected to be robust, driven by innovation and efficiency.

Market Segmentation

Pharmaceutical Logistics Market End User Outlook

Pharmaceutical Manufacturers
Healthcare Providers
Retail Pharmacies
Third-Party Logistics Providers

Pharmaceutical Logistics Market Service Type Outlook

Transportation
Warehousing
Distribution
Packaging

Pharmaceutical Logistics Market Mode of Transport Outlook

Air Freight
Sea Freight
Land Transport

Pharmaceutical Logistics Market Temperature Control Outlook

Ambient
Cold Chain
Controlled Room Temperature

Report Scope

Report Attribute/Metric	Details
Market Size 2024	95.88(USD Billion)
Market Size 2035	274.03 (USD Billion)
Compound Annual Growth Rate (CAGR)	9.50% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	FedEx, XPO Logistics, Geodis, DHL, Tibbett Logistics, Lynden Incorporated, Kuehne + Nagel, DB Schenker, Panalpina, IDL Export Services, Agility, UPS, Cegelec, TNT Express
Segments Covered	Service Type, Temperature Control, End User, Mode of Transport, Regional
Key Market Opportunities	Cold chain logistics expansion, Digital supply chain integration, E-commerce growth for pharmaceuticals, Emerging markets access, Sustainable packaging solutions
Key Market Dynamics	Regulatory compliance pressures, Technological advancements in tracking, increasing demand for temperature-sensitive products, growing need for supply chain transparency, and a Rise in e-commerce pharmaceutical sales
Countries Covered	North America, Europe, APAC, South America, MEA
Market Size 2025	110.55 (USD Billion)